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Abstract
Introduction: To investigate the role of interferon-gamma (IFN-g) in the onset and severity of dacryoadenitis in the
CD25 knockout (KO) mouse model of Sjögren Syndrome.
Methods: CD25/IFN-g double KO (gDKO) mice were created by crossbreeding CD25KO and IFN-gKO mice. Mice
were used at 8, 12, and 16 weeks. Lacrimal gland (LG) infiltrating lymphocytes were characterized with flow
cytometry. Tear epidermal growth factor (EGF) concentration was measured with enzyme-linked immunosorbent
assay (ELISA). Quantitative polymerase chain reaction (PCR) evaluated T-cell-related cytokines in LGs. Serum
autoantibodies against M3R in LG lysates were detected with Western blot.
Results: gDKO LG showed lower lymphocytic infiltration at 8 weeks than in the CD25KO parental strain (˜20%
versus ˜60%, respectively), which increased to CD25KO levels at 16 weeks. Flow-cytometry analysis showed an
increase in CD4+ and CD8+ T cells with aging in gDKO LG, similar to that in CD25KO. gDKO had lower levels of
interleukin (IL)-17A, transforming growth-factor (TGF)-b1, IL-21, and CCL20, and higher IL-1b and IL-13 mRNA
transcripts in the LG than in the parental CD25KO strain. Autoantibodies to M3R were observed in both strains and
significantly increased with aging in both strains. CD25KO mice had very low tear EGF concentrations at all ages,
whereas the ear EGF concentration in gDKO mice significantly decreased with aging and inversely correlated with
the presence of M3R autoantibodies and the degree of LG CD4 and CD8+ T-cell infiltration.
Conclusions: The deletion of IFN-g in the CD25KO mice strain delays glandular destruction and preserves glandular
function. M3R autoantibodies increased with aging in both the gDKO and the CD25KO strains. The decrease in LG
function in gDKO correlated with the degree of T-cell infiltration and the presence of M3R autoantibodies.
Introduction
Sjögren Syndrome (SS) is a severe autoimmune disease
that causes inflammation and dysfunction of the lacrimal
and salivary glands. The glandular immunopathology is
characterized by multifocal mononuclear cell infiltration,
initially around the ductules and later surrounding and
replacing secretory acinar cells, leading to decreased secre-
tory function [1,2].
Several mouse strains have been used to study the
pathogenic mechanisms of SS. These include the nonobese
diabetic (NOD), MRL/Lpr, NZB/W F1 mouse, and trans-
forming growth factor (TGF)-b1 and CD25 knockout
(KO) strains [3-11]. The CD25KO mouse develops multi-
organ inflammatory disease, inclusive of exocrine glands
and gastrointestinal tract, and a profound hemolytic
anemia [12,13]. The spontaneous dacryoadenitis that
develops in these mice worsens rapidly with age, with a
moderate infiltration at age 8 weeks that progresses to
complete atrophy and periductal fibrosis at age 16 weeks
[14,15].
IFN-g is secreted by T cells and natural killer cells. This
cytokine plays a crucial role in the pathogenesis of a
number of immune and inflammatory diseases [16-19].
In SS, it has been shown that IFN-g is an early regulator
of the acinar cell pathology by inhibiting the G1 phase of
the acinar cell cycle, altering integrin expression and
decreasing cell viability [5]. It has also been implicated in
the cornification of the conjunctival epithelia in a murine
mouse model of dry eye [20]. Several lines of evidence
indicate that the T-helper (Th)-1 cytokine IFN-g is asso-
ciated with the pathogenesis of SS. High concentrations
of serum IFN-g and high levels of IFN-g mRNA in the
conjunctiva were found in SS patients [21,22]. Expression
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of high levels of IFN-g mRNA in labial salivary gland
biopsies from SS patients was found to correlate with the
degree of T-cell infiltration [23].
Alternative explanations for exocrine dysfunction
include epithelial cell apoptosis, direct effects of cyto-
kines, autoantibodies against nuclear proteins (ANAs),
ribonuclear proteins (Ro/SSA and La/SSB), a-fodrin,
and the muscarinic acetylcholine type 3 receptor (M3R)
or dysregulation of the parasympathetic nervous system
[24]. Previous studies have shown that repeated injection
of sera from SS patients into mice caused a 40% to 60%
decrease in salivary secretory function [25].
The purpose of this study was to investigate the
effects of IFN-g deletion on the pathogenesis of the
dacryoadenitis that develops in CD25KO mice.
Materials and methods
Animals
This research protocol was approved by the Baylor Col-
lege of Medicine Center for Comparative Medicine, and
it conformed to the standards in the ARVO Statement
for Use of Animals in Ophthalmic and Vision Research.
Heterozygous breeder pairs of CD25KO (B6.129S4-
Il2ratm1Dw/J) and IFN-gKO (B6.129S7-Ifngtm1Ts/J) mice in
a C57BL/6 background were purchased from Jackson
Laboratories (Bar Harbor, ME, USA) for establishing
breeder colonies.
To create a CD25/IFN-g double KO (gDKO), IFN-gKO
mice were mated with heterozygous CD25 mice. F1 was
genotyped, and double-heterozygous CD25+/- and IFN-g
+/- mice were mated. F2 offspring were genotyped, and
the mice that were CD25+/- and IFN-g-/- were used as
breeder pairs to generate CD25/IFN-g double-KO
(gDKO) mice.
The genotype of gene-knockout strains was confirmed
by using a previously reported protocol [14]. Mice were
used at ages 8, 12, and 16 weeks. A minimum of 23 ani-
mals per time point (8, 12, and 16 weeks) per strain
(CD25KO, IFN-gKO, gDKO) were used: five for histologic
sections, 10 for flow-cytometry analysis, and eight for
gene-expression studies. In some strains/time point, up to
20 animals were used for flow cytometry.
Neither the CD25KO parental strain nor the IFN-gKO
strain has a gender bias in their pathology [9]. In our
preliminary evaluation, we did not observe a gender dif-
ference in severity of LG infiltration in the newly created
gDKO strain. Therefore, the data represent an average of
both genders (1:1) for each parameter/age.
Histology, periodic acid-Schiff staining, and
immunohistochemistry
Extraorbital lacrimal glands, submandibular glands, small
intestine, kidneys, and eyes were excised, fixed in 10%
formalin, and paraffin embedded, and 8-μm sections
were cut. Sections were stained with hematoxylin and
eosin (H&E) for evaluating morphology. The area of lym-
phocytic infiltration was circumscribed in digital images
of H&E-stained sections, as previously described [9]. In
brief, digital images were analyzed by using NIS Elements
Software: areas of lymphocytic infiltration were circum-
scribed, as well as the total area of the lacrimal gland.
The percentage infiltration was calculated as area of infil-
tration × 100/total area.
For immunohistochemistry, extraorbital LGs from each
strain/time point (n = 5) were excised, embedded in opti-
mal cutting-temperature compound (VWR, Suwanee, GA,
USA), and flash frozen in liquid nitrogen. Sagittal 8-μm
sections were cut with a cryostat (HM 500; Micron, Wal-
dorf, Germany) and placed on glass slides that were stored
at -80°C.
Immunohistochemistry in LG cryosections was per-
formed by using CD4 (BD Pharmigen, San Jose,CA, clone
H129.9, 10 μg/ml), CD8a (BD Pharmigen,San Jose,CA
clone 53e6.7, 3.125 μg/ml), or CD19 (Abcam, Cambridge,
MA clone 6D5, 2 μg/ml) antibodies. Staining was per-
formed with appropriate biotinylated secondary antibodies
(all from BD Pharmingen) and a Vectastain Elite ABC kit
with Nova Red reagents (Vector, Burlingame, CA, USA).
Secondary antibody alone and appropriate anti-mouse
isotype (BD Bioscience, San Diego, CA, USA) were used
as controls. Six sections from each animal/group/time
point were examined and photographed.
Flow-cytometry analysis of infiltrating cells
Single-cell suspensions of LGs from C57BL/6, CD25KO,
IFN-gKO, and gDKO mice at ages 8, 12, and 16 weeks
(minimum of eight up to 20/strain/age) were prepared as
previously reported [9]. In brief, extraorbital lacrimal
glands were excised, minced, and subjected to collagenase
digestion for 1 hour at 37°C under constant agitation.
Collagenase was neutralized by adding complete RPMI
with FBS; cells were filtered by using a 70-μm cell strainer,
centrifuged, and resuspended. Cells were stained with
anti-CD16/32 (BD Pharmingen), followed by cell-surface
staining with FITC-conjugated anti-CD4 (GK 1.5), PE-
anti-CD8 (clone 53-6.7), or APC-B220 (clone RA3-6B2).
Negative controls were stained with isotype antibodies
(BD Pharmingen). Live/dead cell exclusion was visualized
with propidium iodide. A BD LSRII Bench-top cytometer
was used for cytometry, and data were analyzed by using
FlowJo Software (Tree Star Inc.).
RNA isolation and quantitative PCR
Extraorbital LGs from CD25KO, IFN-gKO, and gDKO
were excised, and total RNA was extracted by using the
Arcturus PicoPure RNA Isolation Kit (Applied Biosystems,
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Foster City, CA, USA), quantified by a NanoDrop ND-
1000 Spectrophotometer (Thermo Scientific, Wilmington,
DE, USA), and stored at -80°C. Eight samples per strain/
age were used, and one sample consisted of pooled glands
from the same animal. Samples were treated with DNase
to eliminate genomic DNA contamination (Qiagen, Valen-
cia, CA, USA). First-strand cDNA was synthesized with
random hexamers by M-MuLV reverse transcription
(Ready-To-Go You-Prime First-Strand Beads; GE Health-
care, Inc., Arlington Heights, NJ, USA), as previously
described [9].
Quantitative real-time PCR was performed with spe-
cific MGB probes (Taqman; Applied Biosystems) and
PCR master mix (Taqman Gene Expression Master
Mix), in a commercial thermocycling system (Step
OnePlus Real-Time PCR System; Applied Biosystems).
Murine MGB probes were IL-17A (Mm00439619),
IFN-g (Mm00801778), IL-13 (Mm00434165), IL-21
(Mm00517640), CCL20 (Mm00444228), TGF-b1
(Mm00441724), GATA-3 (Mm00484683), RORgT
(Mm00441139), and IL-1b (Mm00434228).
The copy number of the gene of interest was calculated
by comparing the sample with the gene-specific standard
curve, previously prepared by using commercial mouse
cDNA (Zyagen, San Diego, CA, USA). Samples and stan-
dards were assayed in duplicate. A nontemplate control
and total RNA without retrotranscription were included in
all the experiments to evaluate PCR and DNA contamina-
tion of the reagents used.
Tear washings and EGF enzyme-linked immunosorbent
assay
Tear-fluid washings were collected from eight animals/
strain/age and from eight young C57BL/6 mice, by using a
previously reported method [9]. One sample consisted of
tear washings from both eyes of one mouse pooled (2 μl)
in PBS+0.1% BSA (8 μl) and stored at -80°C until the assay
was performed.
The EGF concentration in tear samples was assayed with
a commercial ELISA kit according to the manufacturer’s
protocol (R&D Systems, Minneapolis, MN, USA). The
microplate was read by using an ELISA-reader instrument
(Tecan Infinite M200) equipped with Magellan V6.55 soft-
ware. Biologic replicate samples were averaged. Results are
presented as mean ± standard deviation (pictograms per
milliliter).
SSA and SSB autoantibodies ELISA
Serum was collected by cardiac puncture after death from
eight animals/strain/age and from eight young C57BL/6
mice. SSA and SSB were individually assayed in serum by
using commercially available ELISA kits (Calbiotech,
Spring Valley, CA, USA) according to the manufacturer’s
instructions.
Western blot
C57BL/6 extraorbital LGs (n = 4 animals) were excised
and lysed in RIPA buffer containing a protease inhibitor
cocktail tablet. Total protein concentrations were mea-
sured with a Micro BCA protein kit (Pierce, Rockford,
IL, USA), and 200 μg of protein/sample was separated
with SDS-polyacrylamide gel electrophoresis, blocked,
and incubated overnight at 4°C with either a commercial
antibody raised against M3R (4 μg; Santa Cruz Biotech-
nology) or serum from CD25KO, gDKO, and C57BL/6
mice (diluted at 1:1,500), and appropriate HRP-conjugated
secondary antibodies were applied (Pierce; 1:2,000). Signals
were detected by using the ECL Plus Detection Reagents
(Amersham Place, Little Chalfont, Buckinghamshire, UK),
and the images were acquired and analyzed with a Kodak
Image Station 2000R (Eastman-Kodak, New Haven, CT,
USA). Specificity of the antibody was confirmed with pre-
incubation assays with the same peptide used to generate
the antibody. Loading control studies were performed by
immunoblotting all four LG lysates with a commercial
antibody anti-b actin (Sigma-Aldrich; 1:5,000 dilution).
Location of an immunodetected band in LG lysates was
compared with a positive control (brain lysates; Santa
Cruz Biotechnology). Net bands intensities were measured
with Kodak 1D v3.6 software in digital images.
Co-immunoprecipitation procedure
Four and eight micrograms of commercial affinity-puri-
fied goat polyclonal antibody anti-M3R or 20 and 40 μl
each of two sera from two 16-week-old CD25KO mice
were covalently cross-linked to 50 μl of Dynabeads pro-
tein G (Invitrogen, Dynal AS, Oslo, Norway) according to
the manufacturer’s protocol. Proteins from two different
mouse whole-LG cell lysates (100 to 200 μg) were used
as an antigen-containing sample. The immunoprecipi-
tated Dynabeads complexes were washed and separated
on a Dyna-Mag-2 magnet. Eluted proteins and washes
were processed for Western blot analysis. When samples
were immunoprecipitated by using the M3R antibody,
they were further blotted by using the CD25KO serum
and vice versa.
Statistical analysis
The Kruskal-Wallis test was used to determine overall sta-
tistical significance followed by a two-tailed t test for indi-
vidual differences in gene expression, EGF concentration,
and CD4/CD8 infiltration. Nonlinear regressions were
used to evaluate the correlation of tear EGF concentration
versus muscarinic 3-receptor densities and CD4+ T-cell
and CD8+ T-cell percentages by using data collected from
all the strains. Statistical significance was calculated by
Spearman correlation, which makes no assumption about
the normality of data. P ≤ 0.05 was considered statistically
significant. These tests were performed by using GraphPad
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Prism 5.0 software (GraphPad Software Inc., San Diego,
CA, USA).
Results
Deletion of IFN-g delays the onset of dacryoadenitis in
CD25KO mice
Previous studies in the NOD spontaneous SS model
showed that IFN-g has a critical role in the submandibular
but not in lacrimal-gland disease [5]. The offspring of
gDKO mice appeared normal at birth and after weaning.
Similar to parental CD25KO mice, enlargement of lym-
phoid tissues were observed macroscopically, and micro-
scopic lymphocytic infiltration of small intestine,
submandibular glands, and kidneys was observed in DKO
mice, although to a lesser extent than in the CD25KO par-
ental strain (data not shown).
Macroscopically, we observed the gDKO LGs to have
normal appearance and size at 8 weeks of age, similar to
the IFN-gKO and C57BL/6. Young CD25KO LGs showed
acinar atrophy, periductal fibrosis, and intense lymphocytic
infiltration occupying up to 50% of the total area of the
gland (Figure 1A, B). The dacryoadenitis in CD25KO wor-
sened with age, progressing to total acinar loss, ductal pro-
liferation, and atrophy at age 16 weeks. Compared with
the CD25KO parental strain, young gDKO mice showed
less cell infiltration (˜20%), with preservation of architec-
ture and normal-appearing acini occupying about 70% of
LGs, with progressive increase in the area of lymphocytic
infiltration in the LGs with aging, reaching 80% of total LG
area at 16 weeks, whereas the remainder of the LG was
atrophic with few normal acini remaining (Figure 1A, B).
Comparatively speaking, the appearance of gDKO 16W
LG resembled CD25KO 12W LG regarding the amount of
inflammation that was seen. IFN-gKO LGs had minimal
lymphocytic infiltration at all time points.
Analysis of the lymphocytic populations infiltrating the
lacrimal glands of CD25KO and gDKO
The better to characterize the lymphocytic infiltration,
LG sections from all groups were immunostained for
CD4+, CD8+ T cells, and B cells and quantified with flow
cytometry (Figure 1 and see Additional file 1).
Flow cytometry showed a predominance of CD8+ T cells
over CD4+ T cells in both gDKO and CD25KO LG at age
8 weeks of age (Figure 1C and Additional file 1). We
observed that gDKO-8W showed less T-cell infiltration
than the CD25KO and IFN-gKO parental strains, but
showed a progressive increase in CD4+ and CD8+ cells
(Figure 1C, E), in roughly equal proportions with aging,
mainly around the epithelial ducts (Figure 1D, F). Minimal
T-cell infiltration was observed in control C57BL/6 ([15]
and data not shown) and IFN-gKO LG (Figure 1D, F).
CD4+ T-cell infiltration was observed in the same areas as
CD8 infiltration in all strains (Figure 1F) and was noted to
increase with age in both CD25KO and gDKO strains
(Figure 1E). Flow cytometry (Additional file 1) confirmed
a progressive increase of CD4+ T cells with aging in these
strains, reaching statistical significance in gDKO at age
16 weeks (Figure 1E). The increase in CD4+ T cells in
gDKO was accompanied by an increase in CD8+ T cells
(Figure 1C, E).
Immunohistochemistry for B cells by using the CD19
antibody showed that few sparse infiltrating CD19+ cells
were seen in IFN-gKO and gDKO LG at ages 8 and
12 weeks (Figure 2A); whereas they were slightly more fre-
quent at age 16 weeks (Figure 2). In the CD25KO strain,
the presence of B cells was much more variable within the
same age group; two types of infiltration patterns were
observed. The first pattern resembled the one observed in
the IFN-gKO and gDKO LGs, whereas B cells were
dispersed. The second was suggestive of germinal center
formation within the LG (Figures 2A and 2B), and it was
seen only in the CD25KO mouse strain. Both patterns
were seen with similar frequency in the CD25KO LGs.
Flow-cytometry analysis (Figure 2C) confirmed the
increase in B220+ cells at age 16 weeks in both gDKO
and IFN-gKO, and the increased amount of infiltrating B
cells in CD25KO at all ages when compared with gDKO
(Figure 2D).
Cytokine profile in CD25KO, IFN-gKO, and gDKO
Previous studies showed that administration of IL-1 to
LGs induces release of proinflammatory cytokines,
induces lymphocytic infiltration, and decreases LG func-
tion [26,27]. Real-time PCR showed that IL-1b mRNA
transcripts were present at low levels at age 8 weeks in all
three strains, CD25KO, gDKO, and IFN-gKO. At age 12
weeks, a significant increase was noted in the gDKO
strain (Figure 3). It is interesting to note that the peak of
IL-1b accompanied the increase in lymphocytic infiltra-
tion in the LGs of gDKO mice, a finding that we also
observed in our previously reported study showing pro-
gressive CD4+ T-cell infiltration of the LGs after pharma-
cologic blockade of LG secretion [28].
To characterize the T-helper phenotype associated with
dacryoadenitis, we evaluated levels of mRNA transcripts
encoding Th-1, Th-2, and Th-17-associated genes by
using quantitative real-time PCR in CD25KO and gDKO
mice. As a quality control, IFN-g was assayed in LGs of
gDKO and IFN-gKO mice. As previously published [9],
IFN-g mRNA levels were elevated in the parental
CD25KO strain compared with C57BL/6 control mice
(data not shown), but they were absent in gDKO and
IFN-gKO (Figure 3). A significant increase in the level of
the transcripts of the IFN-g was observed in CD25KO at
12W, with a subsequent decrease at 16W.
Significantly higher levels of Th-17-pathway genes
(IL-17A, TGF-b1, IL-21, RORgT, and CCL20) were found
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Figure 1 Histology and T-cell infiltration in lacrimal gland (LG). (A) Total cell infiltration measured in digital images of hematoxylin/eosin
(H&E)-stained LG sections of C57BL/6, CD25KO, gDKO, and IFN-gKO mice at ages 8, 12, and 16 weeks (8W,12W,16W, respectively).
(B) Representative images of H&E-stained LGs from mice aged 8 to 16 weeks. The blue-dotted circle is a higher magnification of the area
demarcated by the black dotted circle in IFN-gKO mice at age 8 weeks. Scale bar, 100 μm. (C) Bar graphs showing mean ± standard deviation of
percentage of CD8+ T cells gated in LG isolates with flow cytometry in C57BL/6, CD25KO, gDKO, and IFN-gKO mice at ages 8, 12, and 16 weeks.
Data are presented as mean ± standard deviation of 10 to 20 individual samples/strain/time point. (D) Representative images of
immunohistochemistry for CD8-positive T cells in the LGs of all three strains at different ages. Positive cells are stained red. Scale bar, 50 μm.
(E) Bar graphs showing mean ± standard deviation of percentage of CD4+ T cells gated in LG isolates with flow cytometry in C57BL/6, CD25KO,
gDKO, and IFN-gKO mice at ages 8, 12, and 16 weeks. Data are presented as mean ± standard deviation of 10 to 20 individual samples/strain/
time point. (F) Representative images of immunohistochemistry for CD4-positive T cells in the LGs of IFN-gKO, gDKO, and CD25KO mice at ages
8, 12, and 16 weeks. Positive cells are stained red. Scale bar, 100 μm. *P < 0.05; **P < 0.01; ***P < 0.001 intrastrain comparison versus age
8 weeks.
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in 8-week-old CD25KO compared with young gDKO
mice (Figure 3). Levels of IL-17A, IL-21, and CCL20
mRNA decreased with time in CD25KO mice, whereas
they remained at similar levels in gDKO and IFN-gKO
mice. No change was found in TGF-b1 expression with
aging.
The level of IL-13 mRNA transcript was higher in the
gDKO strain at 8 and 12 weeks compared with CD25KO
mice, but showed a significant decrease at age 16 weeks.
Similar to IL-1b, the increase of IL-13 mRNA at age
12 weeks paralleled the increase in cell infiltration in LG
sections.
Aging increases muscarinic receptor autoantibodies in
CD25KO and gDKO mice
To investigate the presence of autoantibodies, we per-
formed ELISA for SSA and SSB in serum of CD25KO,
IFN-gKO, and gDKO mice by using commercially available
ELISA kits. No SSA and SSB antibodies were detected in
serum from any strain at any age by using these kits (data
not shown).
Serum autoantibodies to the muscarinic 3 receptor
have been detected in a high percentage of patients with
SS [29,30] and have been proposed as a marker of dry
eye in SS [29]. Because we still observed progression of
disease in the absence of IFN-g, we hypothesized that
M3R autoantibodies could be involved in the progressive
LG immunopathology with aging. Immunoblotting studies
(Figure 4), by using four different C57BL/6 LG cell lysates
as the antigen source, identified a major band ˜60 kDa
detected with the serum from C57BL/6, CD25KO, and
gDKO at age 8 weeks at similar intensities. Loading con-
trol with b-actin antibody was also performed (data not
shown) and was used to normalize M3R expression.
A smaller band ˜45 kDa was occasionally seen (Figure 4F).
Aging significantly increased the M3R/b-actin ratio in
both CD25KO and gDKO mice (Figure 4E).
Confirmatory immunoprecipitation assays (by using the
commercial antibody to pull down M3R antigen (4 μg and
8 μg) from total LG protein lysates and blotted by using
the CD25KO serum) showed that M3R antigen that
belonged to immune complexes was correctly identified
by CD25KO serum, whereas remaining washes containing
protein without precipitation yielded no band (washes,
lanes 4 and 5 of Figure 4F). These results were confirmed
by using the CD25KO serum in the first step of the
co-precipitation, and bands were correctly identified in the
immunoprecipitate by using the commercial antibody
(data not shown).
Deterioration of LG function with aging
Because EGF in tears is generally accepted to be exclu-
sively secreted from the LGs, we measured EGF in tears
of all mouse strains as a measure of LG function (Figure
5A). We observed that CD25KO mice of all ages had
significantly lower EGF concentration in tear washings
Figure 2 B-cell infiltration in lacrimal gland (LG). (A) Representative images of CD19+ cells in the LGs of IFN-gKO, gDKO, and CD25KO mice at
ages 8, 12, and 16 weeks (8W,12W,16W, respectively). CD25KO 1 and 2 are two different animals of the same age. Positive cells are stained red.
Scale bar, 100 μm. (B) High magnification of black square in LG at age 16 weeks in all three strains. Scale bar, 50 μm. (C) Representative flow-
cytometry plots of freshly isolated cells from LGs of different strains stained with B220-APC conjugated antibody (x axis) versus forward-scatter
area (FSC-A, y axis). Lymphocytes were gated based on characteristic light-scatter properties; single lymphocytes were gated based on forward-
scatter height versus forward-scatter area (FSC-A), and dead cells were excluded with propidium iodide. (D) Bar graph showing mean ± standard
deviation of percentage of B220+ cells gated in LG isolates with flow cytometry at ages 8, 12, and 16 weeks (8W,12W,16W, respectively).
*P < 0.05 intrastrain comparison; **P < 0.01 intrastrain comparison versus age 8 weeks.
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compared with young C57BL/6 mice, indicating their
profound impairment in LG secretion at all time points.
Young gDKO mice already showed a significant decrease
in EGF concentration, whereas mild to moderate LG
infiltration was noted (Figure 1); however, a significantly
progressive decrease in levels of tear EGF was observed
with aging from 8 to 16 weeks (Figure 5A).
Because the decrease in tear EGF concentration was
accompanied by worsening dacryoadenitis and LG
destruction, we correlated EGF levels with the factors that
also increased with aging (that is, M3R autoantibodies and
T-cell infiltration). We observed that tear EGF concentra-
tions showed a significant inverse correlation with M3R
band densities, percentage of CD4+ and CD8+ T cells mea-
sured with flow cytometry (Figure 5B to D; P = 0.001; P =
0.004; P = 0.002, respectively).
Discussion
We describe in this study that deletion of IFN-g delays
the onset and severity of dacryoadenitis in the CD25KO
mouse strain that develops autoimmune manifestations
resembling SS. The autoimmunity in the LGs of the
gDKO mouse was accompanied by an increase in CD4+,
CD8+ T- and B-cell infiltration with aging from ages 8
to 16 weeks, an increase in M3R autoantibodies, and a
concomitant decrease in EGF concentration in tears.
The infiltration with CD4+ and CD8+ T cells and M3R
autoantibodies correlated with the impairment in LG
secretory activity by using tear EGF concentration as a
measure of function. Lysates of gDKO LG used for gene
expression showed a different T-cell-related cytokine
profile than the CD25KO parental strain, where a signif-
icant peak in IL-1b and IL-13 expression was observed
at age 12 weeks.
Genetic deletion of IFN-g in CD25KO mice did not
abolish development of autoimmunity; rather, it delayed
its onset and attenuated the severity. Our results agree
with the findings of Peck and colleagues [5] that showed
that deletion of IFN-g and IFN-g-receptor genes in the
susceptible NOD mouse strain reversed the lymphocytic
infiltration of the submandibular glands and the salivary
secretory dysfunction, but had no effect on the severity of
Figure 3 Quantitative gene analysis of mRNA copies in lacrimal gland. T-helper-associated cytokines and transcription factors and
proinflammatory cytokine IL-1b were investigated in lacrimal glands of CD25KO, gDKO, and IFN-gKO mice at ages 8, 12, and 16 weeks. Bars
indicate mean ± standard deviation of number of copies from eight individual samples. **P < 0.01 intrastrain CD25KO comparison; ^^ and ^^^,
P < 0.01 and P < 0.001 intrastrain gDKO comparison versus age 8 weeks, respectively.
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lacrimal gland disease [5]. However, findings in the NOD/
IFN-gKO combined with our findings in the gDKO mice
suggest that IFN-g is not entirely responsible for the LG
immunopathology in SS.
In this present study, the presence of inflammatory cells
correlated with the loss of LG function, by using tear EGF
concentration as a measure of function. LGs in young
CD25KO mice showed extensive infiltration and EGF
levels that were already markedly decreased, whereas the
less-severe gDKO mice that had significantly smaller areas
of LG infiltration still had measurable tear EGF at
8 weeks, albeit significantly lower than that in C57BL/6
wild-type mice controls. With aging, tear EGF concentra-
tion in gDKO mice showed a progressive decrease that
paralleled the increase in T-cell infiltration. EGF expres-
sion and secretion is regulated differently from fluid pro-
duction, so it may be appropriate to state that tear EGF is
one conveniently obtained measure of LG function.
Lacrimal insufficiency is responsible for some severe forms
of dry eye and may be caused in part by cytokines such as
IL-1 [26,27] that are released by infiltrating cells or
stressed glandular epithelial cells [31,32]. Previous studies
found a correlation between EGF and the severity of ocu-
lar-surface disease [33].
The proinflammatory and apoptotic effects of IL-1 in the
LG have been extensively studied by Zoukhri and collea-
gues [26,34-37]. In one of their experiments, they showed
that a single dose of IL-1 into the extraorbital LG induced
a mild decrease in LG secretion while inducing a robust
yet reversible (7 to 13 days), inflammatory response that
led to destruction of lacrimal gland acinar epithelial cells
[34]. In our studies, the peak of IL-1b (age 12 weeks)
preceded the greatest increase in lymphocytic infiltration
(age 16 weeks), suggesting that similar to Zoukhri’s studies
[26,34-37], IL-1b may be critical in inducing an inflamma-
tory response that happens after the peak of IL-1b. Worth
Figure 4 Western blot analysis of muscarinic 3 receptor. Extraorbital lacrimal glands (LGs; n = 4) were lysed and processed by using different
antibodies/serum at all ages. Representative images are shown; the number after “LG” indicates the ID of LG used for that particular Western
blot. (A) Representative Western blot of LG2 lysates blotted with M3R antibody. (B through D) Representative Western blot of LG lysates blotted
with C57BL/6 (B, LG3), gDKO (C, LG4), or CD25KO (D, LG3) sera used to generate the bar graph in E of net band densities (arbitrary values). 8W,
8 weeks; 16W, 16 weeks. (E) Mean ± standard deviation M3R net band densities normalized by b-actin band densities in Western blots of LG
lysates blotted C57BL/6, gDKO, or CD25KO sera at different ages. (F) Co-immunoprecipitation studies. LGs were co-immunoprecipitated with
either 4 or 8 μg of muscarinic 3 receptor antibody (lanes 2 and 3) and blotted with CD25KO-16W serum. Excess proteins that were not
precipitated (Wash 1 (W1) and wash 2 (W2), lanes 4 and 5, respectively) were included in the gel and blotted as negative controls. LGs and brain
lysates (lane 1 and 6) that were not immunoprecipitated were included in the gel as positive controls.
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noting, all inflammatory cytokines were decreased at age
16 weeks in gDKO LGs, suggesting an atrophic, end stage.
Interestingly, the gDKO mice showed elevated copies of
IL-13 mRNA at ages 8 and 12 weeks, compared with the
CD25KO parental strain. In vitro interplay between IFN-g
and IL-13 in the generation of polarized Th-1 and Th-2
CD4+ T cells was previously reported [38]. In vivo, the
addition of IFN-g was noted to antagonize the goblet cell
hyperplasia induced by IL-13 in lungs [38]. Adoptive
transfer of IFN-g-producing Th-1 cells also suppressed
goblet cell hyperplasia in an asthma mouse model [39]. In
our experimental dry-eye model, in which wild-type mice
are subjected to a drafty low-humidity environment, and
lacrimal gland secretion is pharmacologically inhibited
[22,40], we demonstrated that IL-13 is a homeostatic fac-
tor for conjunctival goblet cells, whereas IFN-g suppresses
maturation of these cells [41]. Adoptive transfer of CD4+
T cells from donor mice subjected to desiccating stress
increased corneal epithelial apoptosis; however, topical
neutralization of IFN-g in immunodeficient adoptive trans-
fer recipients prevented corneal epithelial apoptosis [42].
In another experiment, we showed that increased acti-
vated-caspase-3 and -8 and TUNEL immunoreactivity
were noted in conjunctival epithelia in B6 mice compared
with IFN-gKO mice after desiccating stress, and exogenous
IFN-g administration further increased these parameters
[43].
We found that both gDKO and CD25KO strains devel-
oped increased levels of serum M3R autoantibodies with
aging that inversely correlated with tear EGF concentra-
tion. The target autoantigen(s) in the dacryoadenitis that
develops in the CD25KO strain has not been identified.
We did not detect SSA or SSB autoantibodies in the sera
of these autoimmune strains, but we did find serum reac-
tivity to LG proteins with an identical size as the M3R,
suggesting that this may be a target antigen. Antibodies
against M3R were more commonly detected in the serum
of patients with primary and secondary SS than in those
with other autoimmune diseases, such as rheumatoid
arthritis and systemic lupus erythematosus, or healthy sub-
jects. Elegant experiments have shown that administration
of human sera to mice causes either a stimulatory or inhi-
bitory effect in lacrimal and submandibular gland secretion
[25,29,44,45]. Iizuka and colleagues [46] demonstrated that
RAG1-/- adoptive transfer recipients of CD3+ T cells
isolated from M3R-/- mice immunized with murine M3R
peptides developed LG infiltration and destruction of sali-
vary glands [46].
One major problem in the CD25KO parental strain is
the lack of T-regs. Recent studies showed that deficient
Figure 5 Lacrimal gland function. (A) Epidermal growth factor (EGF) concentration measured in tear washings from different strains. NT, not
tested. (B through D) Spearman correlations between tear EGF concentrations and muscarinic 3-receptor band densities (B, measured in
Western blot; P = 0.001), lacrimal gland (LG) CD8+ T (C, P = 0.002), and CD4+ T cells (D, P = 0.004). Percentage of CD8 and CD4 infiltration was
measured with flow cytometry. R2, coefficient of determination.
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T-reg cell function may contribute to the development of
multiorgan systemic autoimmune disease [47]. Sponta-
neous development of dacryoadenitis and keratoconjuncti-
vitis is observed in mouse strains with defective T-reg
function, such as the CD25KO strain used in these experi-
ments, as well as the TGF-b1KO. In NOD mice, the dele-
tion of T-reg cells worsens autoimmune activity [48].
Conclusions
Our results show that the deletion of IFN-g in the
CD25KO mouse strain delays glandular destruction and
preserves lacrimal glandular function. We also showed
that M3R autoantibodies increased with aging in both
gDKO and CD25KO strains. Taken together, our findings
show that IFN-g is not the sole contributor in the
dacryoadenitis that develops in this SS mouse model and
demonstrated, for the first time, the presence of M3R
antibodies in the CD25KO mouse strain.
Additional material
Additional file 1: CD4 and CD8 representative flow cytometry in
lacrimal glands (LGs). Representative flow-cytometry plots of freshly
isolated cells from LGs of CD25KO, gDKO, and IFN-gKO mice stained with
either CD4-FITC-conjugated antibody (x axis) or CD8-PE-conjugated
antibody (y axis) at ages 8, 12, and 16 weeks (8W,12W,16W, respectively).
Lymphocytes were gated based on characteristic light-scatter properties;
single lymphocytes were gated based on forward-scatter height versus
forward-scatter area (FSC-A), and dead cells were excluded with
propidium iodide staining.
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